Bausch + Lomb said that PreserVision Eye Vitamin and Mineral Supplement AREDS 2 formula will be on retail shelves in early May, 2010.
Reportedly, scientific studies showed that the inclusion of high levels of omega-3 fatty acids, lutein and zeaxanthin in the diet supports eye health.
The AREDS2 study, which is currently ongoing and expected to complete in 2013, is sponsored by the National Eye Institute/National Institute of Health and is the second nationwide clinical study to determine whether a combination of vitamins and minerals can further slow the progression of vision loss from AMD.
According to Bausch + Lomb, PreserVision AREDS 2 formula is one of many formulas that are being evaluated in the study.
Bausch + Lomb’s core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments and ophthalmic pharmaceuticals.